4
Changes in Ownership
BlossomHill Therapeutics, Inc. Filed Acc 0001840599-26-000003
Director acquired 578,524 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
Agrawal Sundeep · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-08-10 | Conversion : show line 1 in the form | +578,524 | 578,524 | I |
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-08-06 | Grant or award : show line 2 in the form Director Stock Option (Right to Buy) | +23,904 | 23,904 | D |
| 2026-08-10 | Conversion : show line 3 in the form Series B Preferred Stock | −578,524 | 0 | I |
Loading xslF345X06/form4-08102026_100855.xml…